Quarterly report [Sections 13 or 15(d)]

Stock-Based Compensation (Tables)

v3.25.3
Stock-Based Compensation (Tables)
 9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Activities
Following is a summary of stock option activities for the nine months ended September 30, 2025:
Options Weighted
Average
Exercise Price
Weighted
Average
Grant Date
Fair Value
Weighted
Average
Remaining
Life
(years)
Intrinsic
Value
Outstanding – January 1, 2025 5,124,516  $ 0.19  $ 0.23  3.0
Exercised (1,977,499) 0.18  0.12  $ 6,173 
Expired (21,840) 0.31  0.11 
Outstanding – September 30, 2025
 3,125,177  $ 0.19  $ 0.31  3.3 $ 11,997 
Exercisable as of September 30, 2025
 3,125,177  $ 0.19  $ 0.31  3.3 $ 11,997 
Summary of Restricted Stock Activity

Restricted Stock Units
Weighted Average Grant Date
Fair Value
Non-vested – January 1, 2025 9,286,110  $ 4.10 
Granted
5,749,265  3.00 
Vested
 (3,468,117) 4.06 
Forfeited
 (1,179,652) 3.72 
Non-vested – September 30, 2025 (1)
 10,387,606  $ 3.85 
(1) 4,461,115 are PSUs that will vest subject to the achievement of Adjusted EBITDA and Free Cash Flow goals by the Company as discussed above. Includes 2,950,219 awards (RSUs and PSUs) held by the Company’s former Chief Executive Officer that were modified in connection with the sale of the Passenger business. The modification changed the vesting conditions but did not affect the number of awards outstanding. See Note 3 for additional information.
Summary of Stock-Based Compensation Expense
Stock-based compensation expense for stock options and restricted stock units in the unaudited interim condensed consolidated statements of operations is summarized as follows:
Three Months Ended September 30, Nine Months Ended September 30,
2025 2024 2025 2024
Software development
$ 77  $ 118  $ 307  $ 199 
General and administrative (1)
 1,505  4,806  9,933  13,587 
Selling and marketing
 64  201  132  508 
Total stock-based compensation expense (2)
 $ 1,646  $ 5,125  $ 10,372  $ 14,294 
(1) Includes a credit of $2,873 due to the modification of awards as described above.
(2) Total stock-based compensation expense for the three and nine months ended September 30, 2025 and 2024 include accrued expenses.